Nab-paclitaxel in clinical practice: preliminary results from MANTEL Study

被引：0
|
作者：
Vanella, P. [1 ]
Garrone, O. [1 ]
Saggia, C. [2 ]
Vandone, A. M. [1 ]
Vellani, G. [3 ]
Miraglio, E. [1 ]
Castiglione, F. [4 ]
Merlano, M. C. [1 ]
机构：
[1] Osped Insegnamento, AOS Croce & Carle, Cuneo, Italy
[2] AO Maggiore Carita, Novara, Italy
[3] ASL TO 4, Chivasso, Italy
[4] Osped S Lazzaro, Alba, Italy
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw337.46
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
F46
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer - Results of a phase 1b clinical trial
    Zhang, Danmei
    Westphalen, C. Benedikt
    Quante, Michael
    Waldschmidt, Dirk T.
    Held, Swantje
    Kuetting, Fabian
    Dorman, Klara
    Heinrich, Kathrin
    Weiss, Lena
    Boukovala, Myrto
    Haas, Michael
    Boeck, Stefan
    Heinemann, Volker
    Probst, Victoria
    [J]. EUROPEAN JOURNAL OF CANCER, 2024, 201
  • [42] Preliminary results of a phase 1 study of sea-CD40, gemcitabine, nab-paclitaxel, and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (PDAC)
    Bajor, David Lawrence
    Gutierrez, Martin
    Vaccaro, Gina M.
    Masood, Ashiq
    Brown-Glaberman, Ursa
    Grilley-Olson, Juneko E.
    Kindler, Hedy L.
    Zalupski, Mark
    Heath, Elisabeth I.
    Piha-Paul, Sarina Anne
    Zhou, Peigen
    Lu, Hailing
    Ansari, Sahar
    Hayman, Jonathan
    Schmitt, Michael W.
    Coveler, Andrew L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [43] Weekly nab-Paclitaxel in Metastatic Breast Cancer - Summary and Results of an Expert Panel Discussion
    Jackisch, Christian
    Lueck, Hans-Joachim
    Untch, Michael
    Bischoff, Joachim
    Mueller, Volkmar
    Schmidt, Marcus
    Thill, Marc
    Kiechle, Marion
    [J]. BREAST CARE, 2012, 7 (02) : 137 - 143
  • [44] Final results for gemcitabine with nab-paclitaxel in neoadjuvant treatment of resectable pancreatic adenocarcinoma: GAIN-1 study
    Sliesoraitis, Sarunas
    Desai, Neelam Vijay
    Trevino, Jose Gilberto
    Hughes, Steven J.
    Ziotecki, Robert
    Lightsey, Judith L.
    Ivey, Alison Marguerite
    Allegra, Carmen Joseph
    Dang, Long H.
    Daily, Karen Colleen
    Behrns, Kevin
    Liu, Chen
    Chauhan, Shailendra
    Collinsworth, Amy L.
    Lu, Xiaomin
    George, Thomas J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [45] Efficacy and safety of nab-paclitaxel 125 mg/m2 and nab-paclitaxel 150 mg/m2 compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69)
    Furlanetto, Jenny
    Jackisch, Christian
    Untch, Michael
    Schneeweiss, Andreas
    Schmatloch, Sabine
    Aktas, Bahriye
    Denkert, Carsten
    Wiebringhaus, Hermann
    Kuemmel, Sherko
    Warm, Mathias
    Paepke, Stefan
    Just, Marianne
    Hanusch, Claus
    Hackmann, John
    Blohmer, Jens Uwe
    Clemens, Michael
    Costa, Serban Dan
    Gerber, Bernd
    Nekljudova, Valentina
    Loibl, Sibylle
    von Minckwitz, Gunter
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (03) : 495 - 506
  • [46] Efficacy and safety of nab-paclitaxel 125 mg/m2 and nab-paclitaxel 150 mg/m2 compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69)
    Jenny Furlanetto
    Christian Jackisch
    Michael Untch
    Andreas Schneeweiss
    Sabine Schmatloch
    Bahriye Aktas
    Carsten Denkert
    Hermann Wiebringhaus
    Sherko Kümmel
    Mathias Warm
    Stefan Paepke
    Marianne Just
    Claus Hanusch
    John Hackmann
    Jens Uwe Blohmer
    Michael Clemens
    Serban Dan Costa
    Bernd Gerber
    Valentina Nekljudova
    Sibylle Loibl
    Gunter von Minckwitz
    [J]. Breast Cancer Research and Treatment, 2017, 163 : 495 - 506
  • [47] Nab-paclitaxel results in reduced therapy-related fatigue in mice as compared to Cremaphor-based paclitaxel
    Ray, Maria
    Trammell, Rita
    Ran, Sophia
    Toth, Linda
    [J]. CANCER RESEARCH, 2009, 69
  • [48] Safety and Efficacy Results From ABOUND.70+: nab-Paclitaxel/Carboplatin in Elderly Patients With Advanced NSCLC
    Langer, Corey
    Goldman, Jonathan
    Amiri, Kathy
    Anderson, Eric
    DakhiLs, Shaker
    Haggstrom, Daniel
    Jotte, Robert
    Konduri, Kartik
    Modiano, Manuel
    Ong, Teng
    Sanford, Alexandra
    Smith, David
    Socoteanu, Matei
    Kim, Edward
    Weiss, Jared
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S916 - S917
  • [49] Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in advanced cancers.
    Sen, Shiraj
    Piha-Paul, Sarina Anne
    Kato, Shumei
    Karp, Daniel D.
    Janku, Filip
    Fu, Siqing
    Naing, Aung
    Pant, Shubham
    Tsimberidou, Apostolia Maria
    Subbiah, Vivek
    Kurzrock, Razelle
    Meric-Bernstam, Funda
    Hong, David S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [50] FOLFIRINOX or nab-paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: an observational study
    Servetto, Alberto
    Santaniello, Antonio
    Napolitano, Fabiana
    Foschini, Francesca
    Marciano, Roberta
    Cascetta, Priscilla
    Amato, Anna Rita
    Augurio, Maria Rosaria
    Maresca, Lucia
    De Placido, Pietro
    De Placido, Sabino
    Formisano, Luigi
    Bianco, Roberto
    [J]. FUTURE ONCOLOGY, 2022, 18 (21) : 2643 - 2654
12345